Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines
Abstract Global vaccination programs using live-attenuated oral and inactivated polio vaccine (OPV and IPV) have almost eradicated poliovirus (PV) but these vaccines or their production pose significant risk in a polio-free world. Recombinant PV virus-like particles (VLPs), lacking the viral genome,...
Enregistré dans:
Auteurs principaux: | Mohammad W. Bahar, Claudine Porta, Helen Fox, Andrew J. Macadam, Elizabeth E. Fry, David I. Stuart |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/6d14a9581b7346d2a0e7c0c7fcf06ddd |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Plant-made polio type 3 stabilized VLPs—a candidate synthetic polio vaccine
par: Johanna Marsian, et autres
Publié: (2017) -
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses
par: Rahnuma Wahid, et autres
Publié: (2021) -
Polio postgraduate course
par: Editorial Office
Publié: (1955) -
CHALLENGES FOR POLIO ERADICATION. RISK OF RE-EMERGENCY OF INFECTION IN POLIO FREE COUNTRIES
par: N. I. Romanenkova, et autres
Publié: (2018) -
Salk Anti-Polio Vaccine
Publié: (2017)